Literature DB >> 15154111

Intranasal apomorphine. Nastech Pharmaceutical.

Muammer Kendirci1, Wayne J G Hellstrom.   

Abstract

Nastech Pharmaceutical Co Inc is developing a nasal formulation of apomorphine for the potential treatment of erectile dysfunction and female sexual dysfunction.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15154111

Source DB:  PubMed          Journal:  IDrugs        ISSN： 1369-7056


  1 in total

Review 1.  A comparative review of apomorphine formulations for erectile dysfunction : recommendations for use in the elderly.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Federico Dehò; Luigi Barbieri; Pierre I Karakiewicz; Patrizio Rigatti; Francesco Montorsi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.